{"name":"Infant Bacterial Therapeutics","slug":"infant-bacterial-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IBP-9414","genericName":"IBP-9414","slug":"ibp-9414","indication":"Microbiome restoration in infants (specific indication under investigation in Phase 3)","status":"phase_3"}]}],"pipeline":[{"name":"IBP-9414","genericName":"IBP-9414","slug":"ibp-9414","phase":"phase_3","mechanism":"IBP-9414 is a live biotherapeutic product designed to restore beneficial bacterial populations in the infant microbiome.","indications":["Microbiome restoration in infants (specific indication under investigation in Phase 3)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFB6UGs2N0tTWmNwVldkQVRSNE1JVVUtNlpGNjFFNDRsN2hjaks3OVl5cUUyc3Q5RlVwTVVndUlMUjVPX0FCWUNxXzRnc1gyU3MzeGtZcWhNNA?oc=5","date":"2026-04-02","type":"pipeline","source":"Yahoo Finance UK","summary":"Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) stock price, news, quote and history - Yahoo Finance UK","headline":"Infant Bacterial Therapeutics AB (publ) (IBT-B.ST) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPRUhNaTd2bTFiMGhOalhMZmNrZzMxdVJvOXAxU2RKVVF2bFdkQmo0WlI4NmxwMGFCUUthaXl2SFdyQTA0ODEzbDdfb2pETDZaay1MWHRDOFVadUx3VHZheFlKOU42aGc3OVgxZnRoeUJ3bExGckk0dVdvZGJJM3JHUk5EOEhTZi1UWGQ3bzF5MUQ2QUM3TzFhT01FQmFVa0h6R0VoV0wxcHczRElfSDEwZlZPRmwtYnpOQWlhVlhIczg0S1VJeVRtUlhqNA?oc=5","date":"2026-04-02","type":"pipeline","source":"TipRanks","summary":"Infant Bacterial Therapeutics Issues Corrected Notice for 2026 AGM in Stockholm - TipRanks","headline":"Infant Bacterial Therapeutics Issues Corrected Notice for 2026 AGM in Stockholm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQejdCYUQ5dzRaVkQ2UG5MLUFvOW9oQVM5ckh4TEt3SkJFWHhJTk0wZ29xVi1zcEhFVXRQLWxxYjlGNDQwdlVrZVpJSzRGcFVLcW9tUG1LSEhHOGNpUnhVMzk0UVRpd0ViY2d0dURFWDNPd0VpdHktSTVPSWY2SWFOR0pqMWlfVjVPYzlzc29zdTZ4N0xXb2VpY1lR?oc=5","date":"2026-03-25","type":"pipeline","source":"Britannica","summary":"Genetically modified organism - Medicine, Research, Biotechnology - Britannica","headline":"Genetically modified organism - Medicine, Research, Biotechnology","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-16","type":"pipeline","source":"GlobeNewswire","summary":"$3.25+ Bn Human Microbiome Market Trends and Global - GlobeNewswire","headline":"$3.25+ Bn Human Microbiome Market Trends and Global","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQdTBXSFM0UUEta0d0UXM2ZlFKUGsxMzlBYUxGRjhQVkM2NEMwcXlNRXNlLThLcG41UUczN3dWWVZjalJmZnluNE1BT1dkZXliMC1yX1pVQ2stNWxuMGRlQjFuT3VScGVGZTAwdWRsbWhyNjZPc1JKc0pEcW1jd3VHRjlxS2Vid1JiZTF3R00tVDBURnJIQzBSLQ?oc=5","date":"2025-12-26","type":"pipeline","source":"MarketsandMarkets","summary":"Human Microbiome Drugs Market Report 2026-2031, By Type, Disease, and Geo - MarketsandMarkets","headline":"Human Microbiome Drugs Market Report 2026-2031, By Type, Disease, and Geo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-12-13","type":"pipeline","source":"simplywall.st","summary":"Here's Why We're Not Too Worried About Infant Bacterial Therapeutics' (STO:IBT B) Cash Burn Situation - simplywall.st","headline":"Here's Why We're Not Too Worried About Infant Bacterial Therapeutics' (STO:IBT B) Cash Burn Situation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE0tRG1EMkFkTi16NDdDQ3Q4THI5c1FXSF94SzZoVWtlRWxXc3E0N21WcHUzdHA2UzlBY2RZTFpBV0I3bjBZeWIwa1llWDdaVkt5TllVS29icXFiT2pFSjdEWDNsTlhXU2tFcklUUmNZem1fcGdVeHc?oc=5","date":"2025-10-28","type":"pipeline","source":"labiotech.eu","summary":"11 microbiome biotech companies to watch in 2025 - labiotech.eu","headline":"11 microbiome biotech companies to watch in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOUVJWM2dHVTJZdmpSX09rLXZEeEdtQzhtcVMxeVVyYkRIdTN3SjFJRU5pdEF2T05FdHpyNF9PMVlzLVVnQ3FuX0RIMXNMLTI0UnRsRFlCX1hoMDVvZjYzbFM5dDMzZ3IxZjZleThUdzVPWkpuTEx0ZUVPTl9qU0NJODJnVzRaZXlIR0Y1dERPZkdudHE4QXRtenBTUlJ6c2t1aXE2SEQweVQ2QQ?oc=5","date":"2025-09-30","type":"pipeline","source":"pharmaceutical-journal.com","summary":"Urinary tract infection in children: diagnosis and management - pharmaceutical-journal.com","headline":"Urinary tract infection in children: diagnosis and management - pharmaceutical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPcXVLOUxrd1RGUk1zZDBTTFUwaW1BN0NqWnlpbHBBaENrTUNfVmpDUHBQZXRRcWo3Y1JaOXYwMWk1MFppQmNPNEpySGdfZFVUR2w5V0pjcDJRTjltNVFhWGl3MzRsQlZORUlLNmg0VFRQTXlHdHV5NHFMNzZINk1TOWlUNUtoMElqZUtTR0Mwck0?oc=5","date":"2024-06-25","type":"pipeline","source":"Frontiers","summary":"Current and future methods of probiotic therapy for necrotizing enterocolitis - Frontiers","headline":"Current and future methods of probiotic therapy for necrotizing enterocolitis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE5TU1FnRjlOZzNQb2RONzB6M0IzaVY5ZHFjV1FJUE1hdU5HWEctMWUxWFZFanV6ei1vcnZUQXloZ0ZZYV85OVNINDNLTHR1ekFaZ3JGZkl1TGRwNzdiRlB6YVI0ZGJPaFNUS2NteDNKd3ZWN0ZGWXZ2MGlqaw?oc=5","date":"2023-11-14","type":"pipeline","source":"ScienceDirect.com","summary":"Recent advances in phage therapy for pharmaceutical applications - ScienceDirect.com","headline":"Recent advances in phage therapy for pharmaceutical applications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxNbXhySm9NNzNiN3ZreWhYVl9CTDhtakxXdFZ6d3JPMHdPT0F2V0RuRDQ2bUJjUlRrcEdTVVlnemV2RjRub2EwaDZvQWp5enlVRGY3NlRXaFJ3TFdsZ1k5ZVY4TlRmSTNnTU1tZng4SHFWY0prTTVlcElZc1pDREJ2YlJkWnNfMmp3UzBBcnhQX0F4alBhTm9MdlNmWlZ3a2NSTHZWLW5qN3NyQmZOakxObEZnMlk2RVdTVnRfVGk4M2o2LWszdDI3OGtOT3R4dw?oc=5","date":"2022-06-30","type":"pipeline","source":"NTB Kommunikasjon","summary":"Infant Bacterial Therapeutics AB appoints Maria Ekdahl as CFO - NTB Kommunikasjon","headline":"Infant Bacterial Therapeutics AB appoints Maria Ekdahl as CFO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1OV0tBTzFJWU05ZHM1Y3o1SGcxaVVrQUVLbTIybnRWRHdIaUFnaEIzLTREUnU4NXdMZ2FOMUFvc25oaEFiUGpYTHUzOTdQRm0wX3llakZsbGZ3eTJOVkE?oc=5","date":"2019-01-01","type":"pipeline","source":"Market.us","summary":"Human Microbiome Market Size, Share, Price | CAGR of 27.1% - Market.us","headline":"Human Microbiome Market Size, Share, Price | CAGR of 27.1%","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}